Table 2 Summary of Safety Recommendations for Therapeutic Allergy Procedures (for details, see the text)

Subcutaneous immunotherapy with inhalant allergens

Both O and H

(a) mandatory

(a) available on site (in less than 5 min), or (b) available within 30 min, depending on risk assessment and the immunotherapy protocol used

30 min

Venom immunotherapy

Both O and H

(a) mandatory

(b) should be available on site, (in less than 5 min) or within 30 min, depending on the risk assessment and the immunotherapy protocol used

30 min

Drug desensitization procedures

O or H depending on risk assessment

(a) mandatory

(a) available on site (in less than 5 min)

30 min after acute reactions

Waiting time can be extended to 24-98 h for delayed reactions

Oral immunotherapy for food allergy

Both O and H

(a) mandatory

available within 5 minutess (a) or available within 30 min (b) depending on risk assessment

2 h

Currently not recommended for routine clinical use

Treatment with Anti-IgE and other biologicals

(a) mandatory

(b) available within 30 min

2 h for the first administration;30 min for succesive administration

Treatment with products from human plasma

(a) mandatory

(b) available within 30 min

30 min